ArticleTransplantation and cellular therapy2024

COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics.

Emily A Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.